IRCT20230814059148N1招募中3 期
Evaluating the effect of febuxostat drug administration compared to placebo in septic patients hospitalized in the intensive care unit
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Septic patients who are hospitalized in the intensive care unit
排除标准
- •Patients taking Azathioprine, Mercaptopurine, or Methotrexate at the same time
- •Patients with sensitivity to Febuxostat or Allopurinol or Lactose or any component of the formulation of these drugs
- •Patients with severe liver failure class C (ALT >3×ULN and total serum bilirubin more than 2×ULN)
- •Patients with malignancy
- •Pregnant and lactating women
研究者
相似试验
已完成
不适用
A study to evaluate the effect of febuxostat in heart failure patients with hyperuricemiaHeart failureJPRN-UMIN000021919Kochi Medical School, Kochi University200
已完成
3 期
A clinical trial to study the effect of two drugs, febuxostat and allopurinol in chronic management of hyperuricemia in patients with gout.CTRI/2009/091/000611Sun Pharmaceutical Industries Limited200
已完成
不适用
Study of the effects of febuxostat in patients with diabetic nephropathy.Diabetic nephropathyJPRN-UMIN000015547Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine50
已完成
4 期
Effect of febuxostat on disease progression in patients of chronic kidney disease with high uric acid levels in the blood.CTRI/2014/08/004853Institute of Postgraduate Medical Education and Research Kolkata93
已完成
1 期
Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy VolunteersGoutNCT01563432SK Chemicals Co., Ltd.30